Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study

Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD

(2011) S. Pascoe et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD

(2011) Heinrich Worth et al.   RESPIRATORY MEDICINE

Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease

(2010) James F. Donohue et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design

(2010) Peter J. Barnes et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Efficacy of a new once-daily long-acting inhaled  2-agonist indacaterol versus twice-daily formoterol in COPD

(2010) R. Dahl et al.   THORAX

24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol

(2009) Olivier Bauwens et al.   CURRENT MEDICAL RESEARCH AND OPINION

A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison

(2008) Stephen Rennard et al.   RESPIRATORY MEDICINE